Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

15.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

7.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.9K
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

2.6K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leukemic architecture as a framework for risk stratification in NPM1-mutated acute myeloid leukemia.

Discover oncology·2026
Same author

Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining Method.

Diagnostics (Basel, Switzerland)·2026
Same author

Chimeric Antigen Receptor-T Cells Fate after Infusion: Cellular Kinetics and Molecular Monitoring.

Transplantation and cellular therapy·2026
Same author

Endothelial Cells as Antigen-Presenting Cells. An Historical Note.

Clinical anatomy (New York, N.Y.)·2026
Same author

Correction: Cazzato et al. Skin Mycetoma in an 11-Year-Old African Boy: Case Presentation with Emphasis on Histopathological Features and Differential Diagnosis. <i>Dermatopathology</i> 2021, <i>8</i>, 509-514.

Dermatopathology (Basel, Switzerland)·2026
Same author

One Grammar, Many Labels: Revisiting the Continuum of Myeloid Neoplasms.

Hematological oncology·2026

Related Experiment Video

Updated: Dec 14, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

11.7K

New Insights into Diffuse Large B-Cell Lymphoma Pathobiology.

Antonio Giovanni Solimando1,2, Tiziana Annese3, Roberto Tamma3

  • 1Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine 'G. Baccelli', University of Bari Medical School, 70124 Bari, Italy.

Cancers
|July 16, 2020
PubMed
Summary

Diffuse large B-cell lymphoma (DLBCL) involves malignant B cells and their tumor microenvironment. Understanding the interaction between DLBCL cells and their surroundings is key to addressing disease progression and relapse.

Keywords:
DLBCLangiogenesiscell adhesion mediated drug resistancetumor microenvironmenttumor progression

More Related Videos

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.1K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.1K

Related Experiment Videos

Last Updated: Dec 14, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

11.7K
VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.1K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.1K

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Diffuse large B-cell lymphoma (DLBCL) is the most prevalent form of non-Hodgkin lymphoma (NHL), representing approximately 40% of all NHL cases.
  • The tumor microenvironment plays a critical role in the progression of DLBCL.
  • Understanding the cellular components and their interactions within the microenvironment is essential for assessing DLBCL progression.

Purpose of the Study:

  • To review the role of various cellular components within the tumor microenvironment in DLBCL progression.
  • To analyze the crosstalk between DLBCL cells and their milieu, including niche and angiogenic factors.
  • To provide a molecular and functional recapitulation of DLBCL-tumor microenvironment interactions.

Main Methods:

  • Literature review and analysis of existing evidence on DLBCL tumor microenvironment.
  • Examination of cellular components such as mast cells, macrophages, and lymphocytes.
  • Investigation of interactions between DLBCL cells, stromal cells, and vessels.

Main Results:

  • DLBCL is characterized by malignant B cell proliferation in nodal and extranodal sites.
  • A cancer-friendly microenvironment, induced by DLBCL cells, promotes tumor protection and immune evasion.
  • Interactions with stromal cells and vessels supply nutrients, oxygen, and facilitate immune suppression.
  • Protected niches within tissues serve as reservoirs for residual disease and relapse.

Conclusions:

  • The tumor microenvironment is pivotal in DLBCL progression, offering protection and immune suppression.
  • Understanding DLBCL-milieu crosstalk, niche formation, and angiogenesis is crucial for targeting disease progression and relapse.
  • Further research into these interactions can inform novel therapeutic strategies for DLBCL.